Status:
UNKNOWN
Intravitreal Injection of Bevacizumab and Gas for Diabetic Premacular Hemorrhage With Active Fibrovascular Proliferation
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Diabetic Retinopathy With Premacular Hemorrhage
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Diabetic premacular hemorrhage occurs when blood from preretinal neovascular tissue is entrapped between the retina and the posterior hyaloid in the macular area. It may occur spontaneously or seconda...
Detailed Description
In this study, consecutive cases of acute diabetic premacular hemorrhage and active fibrovascular proliferation will receive intravitreal injection of bevacizumab (1.25 mg in 0.05 mL) and C3F8 (0.2-0....
Eligibility Criteria
Inclusion
- Acute diabetic premacular hemorrhage and minor active fibrovascular proliferation
Exclusion
- Anticoagulant therapy
- Blood diseases associated with abnormal coagulation
- Proliferative retinopathy severe enough to warrant vitrectomy
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT00673296
Start Date
January 1 2007
End Date
December 1 2008
Last Update
May 7 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 10002